Lv11
70 积分 2023-11-07 加入
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
4小时前
已完结
OA11.06 Cemiplimab Monotherapy for First Line Advanced NSCLC Patients with PD-L1 Expression ≥50%: 5-y Outcomes of EMPOWER-Lung 1
1个月前
已关闭
204P A radiomics strategy based on CT intra-tumoral and peritumoral regions for preoperative prediction of neoadjuvant chemoradiotherapy for esophageal cancer
10个月前
已关闭
Clinical-Radiomics Nomogram for Risk Prediction of Esophageal Fistula in Patients with Esophageal Squamous Cell Carcinoma Treated by IMRT or VMAT
10个月前
已完结
Risk of death due to heart disease after radiotherapy for esophageal cancer: A SEER study
11个月前
已关闭
食管癌放射性心脏损伤研究进展
11个月前
已完结
Combining Dosimetric and Radiomics Features for the Prediction of Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer by Machine Learning
1年前
已完结
Cardiac death rates after irradiation for esophageal cancer: An epidemiologic study among esophageal cancer survivors
1年前
已关闭
Study on the Dynamic Changes of Myocardial Injury Markers in Radiotherapy for Esophageal Carcinoma and Its Correlation with Cardiac Dosimetry
1年前
已关闭
Risk Analysis of Pneumonitis in Taxane Therapy After Chemoradiotherapy (Crt) for Patient with Esophageal Cancer
1年前
已完结
皖公网安备34019202002308
